News

New targeted radiopharmaceutical therapy induces remission in pancreatic cancer model

ESTRO 2026: AI tool for radiotherapy can support the global effort to eliminate cervical cancer

ESTRO 2026: Breast cancer that has begun to spread could be controlled for longer with targeted radiotherapy

ESTRO 2026: Just two radiotherapy sessions given over eight days can treat prostate cancer without any extra side effects

ESTRO 2026: Meeting an AI doctor before a real-life consultation improves cancer patients’ understanding and reduces stress

Study reveals why breast cancer becomes more deadly with age

ESTRO 2026: Share proton therapy across national borders and plan five new centres in Romania, Greece, Italy, Northern Ireland and Poland to maximise access for patients in Europe

Screening modestly reduces prostate cancer deaths

Recognising and managing IEC-HS: A life-threatening complication of CAR-T therapy

Researchers identify the mechanism by which genome-doubled tumours evade the immune system in breast cancer

Psychological factors sustaining gastric cancer screening during the COVID-19 pandemic

Gene-edited stem cell transplant shows promise for aggressive blood cancers